相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Neovascularization is a key feature of liver fibrosis progression: anti-angiogenesis as an innovative way of liver fibrosis treatment
Mariia Zadorozhna et al.
MOLECULAR BIOLOGY REPORTS (2020)
Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline
John D. Gordan et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Animal models of NAFLD from a hepatologist's point of view
Daniel Jahn et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2019)
Angiopoietin-2 Promotes Pathological Angiogenesis and Is a Therapeutic Target in Murine Nonalcoholic Fatty Liver Disease
Sander Lefere et al.
HEPATOLOGY (2019)
Role of liver sinusoidal endothelial cells in non-alcoholic fatty liver disease
Adel Hammoutene et al.
JOURNAL OF HEPATOLOGY (2019)
Resolving the fibrotic niche of human liver cirrhosis at single-cell level
P. Ramachandran et al.
NATURE (2019)
TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis-Updated 2019
Bedair Dewidar et al.
CELLS (2019)
Ezetimibe suppresses development of liver tumors by inhibiting angiogenesis in mice fed a high-fat diet
Kouichi Miura et al.
CANCER SCIENCE (2019)
Inflammatory stress and altered angiogenesis evoked by very high-fat diets in mouse liver
Adrian Plaza et al.
ENDOCRINOLOGIA DIABETES Y NUTRICION (2019)
Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism
Sander Lefere et al.
JHEP REPORTS (2019)
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Zobair Younossi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Origins of Portal Hypertension in Nonalcoholic Fatty Liver Disease
Gyorgy Baffy
DIGESTIVE DISEASES AND SCIENCES (2018)
Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis
Oliver Krenkel et al.
HEPATOLOGY (2018)
Systematic review with meta-analysis: risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseases
Jonathan G. Stine et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
The role of hypoxia-inducible factors in metabolic diseases
Frank J. Gonzalez et al.
NATURE REVIEWS ENDOCRINOLOGY (2018)
Serum vascular cell adhesion molecule-1 predicts significant liver fibrosis in non-alcoholic fatty liver disease
S. Lefere et al.
INTERNATIONAL JOURNAL OF OBESITY (2017)
Liver sinusoidal endothelial cells: Physiology and role in liver diseases
Johanne Poisson et al.
JOURNAL OF HEPATOLOGY (2017)
Extracellular vesicles in liver disease and potential as biomarkers and therapeutic targets
Gyongyi Szabo et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Extracellular Vesicles in Angiogenesis
Dilyana Todorova et al.
CIRCULATION RESEARCH (2017)
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study
Erica Villa et al.
GUT (2016)
Portal myofibroblasts connect angiogenesis and fibrosis in liver
Sara Lemoinne et al.
CELL AND TISSUE RESEARCH (2016)
Portal Myofibroblasts Promote Vascular Remodeling Underlying Cirrhosis Formation Through the Release of Microparticles
Sara Lemoinne et al.
HEPATOLOGY (2015)
Vascular Endothelial Growth Factor Promotes Fibrosis Resolution and Repair in Mice
Liu Yang et al.
GASTROENTEROLOGY (2014)
CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis
Josef Ehling et al.
GUT (2014)
Angiotensin-II Type 1 Receptor-Mediated Janus Kinase 2 Activation Induces Liver Fibrosis
Michaela Granzow et al.
HEPATOLOGY (2014)
Neovascularization and oxidative stress in the progression of non-alcoholic steatohepatitis
Mitsuteru Kitade et al.
Molecular Medicine Reports (2014)
The emerging roles of microvesicles in liver diseases
Sara Lemoinne et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2014)
Role of Vascular Endothelial Growth Factor in the Pathophysiology of Nonalcoholic Steatohepatitis in Two Rodent Models
Stephanie Coulon et al.
HEPATOLOGY (2013)
Angiotensin II type 1 receptor antagonist prevents hepatic carcinoma in rats with nonalcoholic steatohepatitis
Yosui Tamaki et al.
JOURNAL OF GASTROENTEROLOGY (2013)
The role of angiotensin II in nonalcoholic steatohepatitis
E. Matthew Morris et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2013)
Bevacizumab Attenuates Hepatic Fibrosis in Rats by Inhibiting Activation of Hepatic Stellate Cells
Yangqing Huang et al.
PLOS ONE (2013)
Lipid-Induced Toxicity Stimulates Hepatocytes to Release Angiogenic Microparticles That Require Vanin-1 for Uptake by Endothelial Cells
Davide Povero et al.
SCIENCE SIGNALING (2013)
Evaluation of inflammatory and angiogenic factors in patients with non-alcoholic fatty liver disease
Stephanie Coulon et al.
CYTOKINE (2012)
The biphasic nature of hypoxia-induced directional migration of activated human hepatic stellate cells
Erica Novo et al.
JOURNAL OF PATHOLOGY (2012)
Classification, Functions, and Clinical Relevance of Extracellular Vesicles
Edwin van der Pol et al.
PHARMACOLOGICAL REVIEWS (2012)
TGF-β Receptor Signaling Pathways in Angiogenesis; Emerging Targets for Anti-Angiogenesis Therapy
Laurens A. van Meeteren et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)
Complementary Vascular and Matrix Regulatory Pathways Underlie the Beneficial Mechanism of Action of Sorafenib in Liver Fibrosis
Dominique Thabut et al.
HEPATOLOGY (2011)
Inhibition of Placental Growth Factor Activity Reduces the Severity of Fibrosis, Inflammation, and Portal Hypertension in Cirrhotic Mice
Christophe Van Steenkiste et al.
HEPATOLOGY (2011)
Hepatic and HSC-specific sorafenib effects in rats with established secondary biliary cirrhosis
Martin Hennenberg et al.
LABORATORY INVESTIGATION (2011)
Angiogenesis in chronic liver disease and its complications
Stephanie Coulon et al.
LIVER INTERNATIONAL (2011)
Molecular mechanisms and clinical applications of angiogenesis
Peter Carmeliet et al.
NATURE (2011)
Role of Cytokines in the Pathogenesis of Non-Alcoholic Fatty Liver Disease
Subir Kumar Das et al.
INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY (2011)
Beneficial Effects of Sorafenib on Splanchnic, Intrahepatic, and Portocollateral Circulations in Portal Hypertensive and Cirrhotic Rats
Marc Mejias et al.
HEPATOLOGY (2009)
Hepatic microcirculation in fatty liver disease
Geoff C. Farrell et al.
ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY (2008)
Hepatic Stellate Cells Secrete Angiopoietin 1 That Induces Angiogenesis in Liver Fibrosis
Kojiro Taura et al.
GASTROENTEROLOGY (2008)
Antiangiogenic treatment with Sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats
Snia Tugues et al.
HEPATOLOGY (2007)
Angiotensin-II and vascular endothelial growth factor interaction plays an important role in rat liver fibrosis development
Hitoshi Yoshiji et al.
HEPATOLOGY RESEARCH (2006)
Leptin-mediated neovascularization is a prerequisite for progression of nonalcoholic steatohepatitis in rats
Mitsuteru Kitade et al.
HEPATOLOGY (2006)
Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis
H Yoshiji et al.
GUT (2003)
Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis
C Corpechot et al.
HEPATOLOGY (2002)
Plasma transforming growth factor-β1 level and efficacy of α-tocopherol in patients with non-alcoholic steatohepatitis:: a pilot study
T Hasegawa et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2001)
分享论文
